Related Experiment Videos
[Drug-induced arrhythmias].
Koichi Mizumaki1, Hiroshi Inoue
1Second Department of Internal Medicine, Toyama Medical and Pharmaceutical University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 26, 2002
Summary
Certain drugs can cause or worsen arrhythmias, particularly Torsade de Pointes (TdP), especially in patients with predisposing factors. Careful drug selection and management are crucial to prevent these cardiac events.
Area of Science:
- Pharmacology
- Cardiology
- Clinical Medicine
Context:
- Drug-induced arrhythmias, including proarrhythmia and arrhythmogenesis, are significant clinical concerns.
- Various drug classes, such as cardiotonics, psychiatric medications, and macrolide antibiotics, can precipitate or exacerbate arrhythmias.
- These arrhythmias encompass bradyarrhythmias, tachyarrhythmias, and notably, Torsade de Pointes (TdP) linked to QT prolongation.
Purpose:
- To review the mechanisms and clinical implications of drug-induced arrhythmias.
- To identify predisposing factors that increase the risk of proarrhythmic drug effects.
- To outline management strategies for proarrhythmia and TdP.
Summary:
- A wide array of medications can induce or worsen cardiac arrhythmias.
- Predisposing factors like advanced age, heart failure, and renal dysfunction potentiate the proarrhythmic potential of drugs.
- Management involves cautious drug administration, addressing predisposing conditions, preventing bradycardia, and magnesium infusion for TdP.
Impact:
- Highlights the critical need for vigilance when prescribing potentially proarrhythmic drugs to at-risk individuals.
- Emphasizes the importance of considering patient-specific factors to mitigate the risk of drug-induced cardiac arrhythmias.
- Provides essential information for clinicians on managing and preventing serious drug-related cardiac events.